首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
NEW HEXAFLUOROALCOHOL-BASED MONOMERS AND PROCESSES OF PREPARATION THEREOF
摘要
申请公布号
CA2586864(A1)
申请公布日期
2006.05.18
申请号
CA20052586864
申请日期
2005.11.14
申请人
INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM);ST-JEAN PHOTOCHIMIE INC.
发明人
KHOJASTEH, MAHMOUD;VARANASI, PUSHKARA RAO;FEGHALI, KHALIL;MOTALLEBI, SHAHROKH;BOUCHARD, LUC;MARCOTTE, IAN;DESILETS, DENIS
分类号
C07C69/74;G03F7/20;H01L21/308
主分类号
C07C69/74
代理机构
代理人
主权项
地址
您可能感兴趣的专利
INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS
HPYY(1-36) Having a Beta-Homoarginine Substitution at Position 35
METHOD FOR OBTAINING A CYTOKINE-RICH COMPOSITION AND COMPOSITION OBTAINED BY MEANS OF THIS METHOD
COMPOSITIONS COMPRISING SEMAPHORINS FOR THE TREATMENT OF CANCER AND METHODS OF SELECTION THEREOF
Therapeutic Process For The Treatment Of The Metabolic Syndrome And Associated Metabolic Disorders
METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATION
COMPOSITIONS AND METHODS FOR ALTERING HUMAN CUTANEOUS MICROBIOME TO INCREASE GROWTH OF STAPHYLOCOCCUS EPIDERMIDIS AND REDUCE STAPHYLOCOCCUS AUREUS PROLIFERATION
PHARMACEUTICAL COMPOSITIONS AND METHODS
BIOCOMPATIBLE POLYMERIC SYSTEM FOR TARGETED TREATMENT OF THROMBOTIC AND HEMOSTATIC DISORDERS
PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
17 Alpha, 21-Dihydroxypregnene Esters as Antiandrogenic Agents
Compounds for the Treatment of Diabetes and Disease Complications Arising from Same
MESOPOROUS DOSAGE FORMS FOR POORLY SOLUBLE DRUGS
NOVEL COMPOUNDS
COMPOSITIONS AND METHODS FOR CARDIOVASCULAR DISEASE
ANTI-FIBROTIC PYRIDINONES
FERRIC CITRATE DOSAGE FORMS
MONOACYLGLYCEROLS AND FAT-SOLUBLE NUTRIENTS FOR USE IN THE TREATMENT OF MALABSORPTION HAVING A NON-MECHANICAL BASIS
COMPOSITIONS FOR THE TREATMENT OF AUTODIGESTION
TOPICAL PHARMACEUTICAL GEL COMPOSITION OF DICLOFENAC SODIUM